Mid-Atlantic Retina

Cherry Hill, New Jersey 19107

1 studies enrolling now · 8 studies all time

What they study most

Age Related Macular Degeneration (ARMD), Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Choroidal Neovascularization, Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration, Macular Degeneration, Age-Related, Macular Edema, Wet Age Related Macular Degeneration, Wet Macular Degeneration, wAMD

Studies at this site

• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) — Recruiting now
• A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
• Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — Running, not enrolling
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
• A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — Stopped early
• Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) — Running, not enrolling
• Eplerenone for the Treatment of Central Serous Chorioretinopathy — Completed